There are many changes to the TRICARE program every year. Sign up for email alerts.

Change Overview

New Home Delivery Pharmacy Services Provider for Specialty Drugs


Effective Mar. 1, 2024, if you fill your specialty drugs through TRICARE Home Delivery, you will start to receive expanded specialty pharmacy services from Accredo Health Group, Inc., (Accredo) – as part of the Express Scripts, Inc (ESI) contracted TRICARE network.

Learn more.

Know Your 2024 TRICARE Health Plan Costs

You may see changes to your TRICARE health plan costs starting on Jan. 1, 2024. These costs may include enrollment fees, premiums, cost-shares, and copayments.

Learn more.

Premium Rate Changes to TRICARE Premium-Based Plans Starting on January 1, 2024, the TRICARE premium-based plans will experience premium rate changes. These plans include TRICARE Reserve Select, TRICARE Retired Reserve, TRICARE Young Adult, and the Continued Health Care Benefit Program.


Learn more
Changes to TRICARE Expected

A new TRICARE contract is expected to start in 2025. The changes will improve the delivery, quality, and cost of your health care services. This includes:

  • Greater provider network flexibility
  • Improved beneficiary choice
  • Enhanced telehealth appointments

In addition, the following states are moving from the East RegionAlabama, Arkansas, Connecticut, Delaware, the District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa (Rock Island area), Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri (St. Louis area), New Hampshire, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas (excluding El Paso area), Vermont, Virginia, West Virginia, and Wisconsin. to the West RegionAlaska, Arizona, California, Colorado, Hawaii, Idaho, Iowa (excludes Rock Island arsenal area), Kansas, Minnesota, Missouri (except St. Louis area), Montana, Nebraska, Nevada, New Mexico, North Dakota, Oregon, South Dakota, Texas (southwestern corner including El Paso), Utah, Washington and Wyoming.:

  • Arkansas
  • Illinois
  • Louisiana
  • Oklahoma
  • Texas
  • Wisconsin

Learn more.

FDA Recall of Certain Sleep and Respiratory Devices

The Food and Drug Administration (FDA) has directed Philips Respironics to recall certain sleep and respiratory devices. This includes certain Constant Positive Airway Pressure (CPAP) devices, Bi-Level Airway Pressure (BiPAP) devices, and some ventilators.

The Military Health System (MHS) has notified all TRICARE-authorized durable medical equipment (DME) providers of the recall. If you think your device may be included in this recall:

  • Check the Philips Respironics patient portal or call 1-877-907-7508 to see if your device is on the recall list.
  • Make sure you have registered your device in the patient portal.
  • Talk with your provider about whether you should stop using your device.

Learn more.

Last Updated 2/1/2024